Q-omics provides the consensus-scored MIR190A profile across patient tissues and cancer cell-line models. MIR190A expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in SKCM. Among the 18 cancer types available for tumor–normal comparison, MIR190A is differentially expressed in 3, with the highest sampling consensus in KIRP. Additionally, MIR190A RNA expression shows 7,102 significant gene co-expression associations, with the highest sampling consensus in LUAD. Together, these results highlight SKCM, KIRP, and LUAD as cancer lineages where MIR190A shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR190A — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR190A survival associations across molecular data types. MIR190A RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR190A RNA expression–survival associations across cancer types. High MIR190A expression shows unfavorable associations in SKCM, LUAD, STAD, READ, LIHC and BLCA. The SKCM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify SKCM as the clearest survival context for MIR190A RNA expression.
This table summarizes MIR190A tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for MIR190A. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR190A shows lower tumor expression in KIRP, KICH and KIRC. The KIRP box plot shows higher MIR190A RNA expression in normal versus tumor tissue (log2 FC = −0.424, t-test p < 0.001).
This table shows molecular features associated with MIR190A in patient tissues and cancer cell lines. In patient samples, MIR190A shows the broadest associations at the RNA and protein expression levels, with LUAD recurring as the lineage with the largest associated feature set.
